Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/1228 stock hub

HKG/1228 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1228is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1228

In the news

Latest news · HKG/1228

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E68.9

P25 10.7P50 17.9P75 38.5

ROEn/a

P25 -14.7P50 2P75 9.4

ROICn/a

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1228 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

156

Groups with data

Currency

CNY

Showing 156 of 156 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	41
Employees Change	-26%
Employees Change Percent	-38.81
Enterprise value	HKD 1.3B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG8587E1061
Last refreshed	2026-05-10
Market cap	HKD 1.4B
Price	HKD 2.3
Price currency	HKD
Rev Per Employee	1,356,624.27x
Sector	Healthcare
Sic	2836
Symbol	hkg/1228
Website	https://www.canbridgepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.2%
EV Earnings	79.64x
EV/Sales	23.61x
P/B ratio	-3.6x
P/E ratio	68.9x
P/S ratio	24.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-185.46%
EBITDA Margin	-158.02%
Gross margin	73.13%
Gross Profit	HKD 40.7M
Gross Profit Growth	-9.26%
Gross Profit Growth Q	-15%
Gross Profit Growth3 Y	-18.26%
Gross Profit Growth5 Y	-7.3%
Net Income	HKD 16.5M
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	29.65%
Profit Margin	29.65%
Profit Per Employee	HKD 402,186
Profitable Years	1
ROA	-41.06
Roa5y	-51.44
ROCE	31.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,489.21%
Cagr3y	15.31%
EPS Growth Quarters	4
EPS Growth Years	1
Revenue Growth	-41.27x
Revenue Growth Q	-31.19x
Revenue Growth Years	0x
Revenue Growth3 Y	-21.82x
Revenue Growth5 Y	-10.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.35
Assets	HKD 184M
Cash	HKD 74.1M
Current Assets	HKD 126.9M
Current Liabilities	HKD 524.4M
Debt	HKD 17.9M
Equity	HKD -380.3M
Interest Coverage	-41.57
Liabilities	HKD 564.4M
Long Term Assets	HKD 57.2M
Long Term Liabilities	HKD 40M
Net Cash	HKD 56.2M
Net Cash By Market Cap	HKD 4.11
Tangible Book Value	HKD -441.2M
Tangible Book Value Per Share	HKD -0.91
WACC	4.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.24
Inventory Turnover	0.94
Net Working Capital	HKD -449.4M
Quick ratio	0.18
Working Capital	HKD -384.1M
Working Capital Turnover	HKD -0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,486.21%
200-day SMA	2.25
3Y total return	53.33%
50-day SMA	2.56
50-day SMA vs 200-day SMA	50over200
All Time High	9.99
All Time High Change	-76.98%
All Time High Date	2021-12-10
All Time Low	0.1
All Time Low Change	2,321.05%
All Time Low Date	2025-01-16
ATR	0.14
Beta	-0.06
Beta1y	1.52
Beta2y	0.74
Ch YTD	-10.16
High	2.36
High52	3.5
High52 Date	2026-02-05
High52ch	-34.29%
Low	2.24
Low52	0.13
Low52 Date	2025-05-13
Low52ch	1,725.4%
Ma50ch	-10.02%
Price vs 200-day SMA	2.18%
RSI	44.66
RSI Monthly	54.86
RSI Weekly	48.84
Sharpe ratio	2.65x
Sortino ratio	6.3
Total Return	-7.55%
Tr YTD	-10.16
Tr1m	-16.36%
Tr1w	13.3%
Tr3m	-25.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -103.2M
Operating margin	-185.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	338,297,805%
Shares Insiders	7.15%
Shares Institutions	11.89%
Shares Out	595,443,347
Shares Qo Q	15.09%
Shares Yo Y	7.55%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	724,716.7x
Bv Per Share	-0.79
Ch1m	-16.36
Ch1w	13.3
Ch1y	1,486.2
Ch3m	-25.57
Ch3y	53.33
Ch6m	27.07
Change	5.02%
Change From Open	2.68
Close	2.19
Days Gap	2.28
Depreciation Amortization	15,795,990.4
Dollar Volume	1,780,200
Earnings Date	2026-03-30
EBIT	HKD -103.2M
EBITDA	HKD -87.9M
EPS	HKD 0.03
F Score	4
Fiscal Year End	December
Founded	2,012
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Ma150	2.4
Ma150ch	-3.97%
Ma20	2.41
Ma20ch	-4.37%
Open	2.24
Position In Range	50
Ppne	588,448.7
Price Date	2026-05-08
Relative Volume	1.08x
Revenue	55,621,595x
Tr6m	27.07%
Volume	774,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/1228 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/1228 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1228?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.9%

Share of float held by funds and institutions

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.5%

Negative means the company is buying back shares.

Technical

HKG/1228 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

+2.2%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

2.65

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1228

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1228 stock rating?

hkg/1228 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1228 analysis?

The full report lives at /stocks/hkg/1228/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1228?

The latest report frames hkg/1228 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1228 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.